[1]
|
WHO Report 2009, “Global Tuberculosis Control: Epi- demiology, Strategy, Financing,” Geneva, World Health Organization, 2009.
|
[2]
|
A. Subramanian and S. Dorman, “Mycobacterium Tu-berculosis in Solid Organ Transplant Recipients,” Amer-ican Journal of Transplantation, Vol. 9, No. s4, 2009, pp. S57-S62.
doi:10.1111/j.1600-6143.2009.02894.x
|
[3]
|
J. M. Aguado, J. Torre-Cisneros, J. Fortun, N. Benito, Y. Meije, A. Doblas, et al., “Tuberculosis in Solid-Organ Transplant Recipients: Consensus Statement of the Group for the Study of Infection in Transplant Recipients (GE- SITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology,” Clinical Infectious Diseases, Vol. 48, No. 9, 2009, pp. 1276-1284. doi:10.1086/597590
|
[4]
|
B. R. Yehia and E. A. Blumberg, “Mycobacterium Tu-berculosis Infection in Liver Transplantation,” Liver Transplantation, Vol. 16, No. 10, 2010, pp. 1129-1135. doi:10.1002/lt.22133
|
[5]
|
M. Donataccio, G. Dalle Ore and D. Donataccio, “The Ministransplant Procedure in Liver Transplantation,” Acta Gastroenterol Belg, Vol. 73, No. 3, 2010, pp. 367-369.
|
[6]
|
S. Nagai, Y. Fujimoto, K. Taira, H. Egawa, Y. Takada, T. Kiuchi, et al., “Liver Transplantation without Isoniazid Prophylaxis for Recipients with a History of Tuberculo-sis,” Clinical Transplantation, Vol. 21, No. 2, 2007, pp. 229-234. doi:10.1111/j.1399-0012.2006.00630.x
|
[7]
|
R. Barcena, E. Oton, M. A. Moreno, J. Fortùn, M. Gar- cia-Gonzalez, A. Moreno, et al., “Is Liver Transplantation Advisable for Isoniazid Fulminant Hepatitis in Active Extrapulmonary Tuberculosis?” American Journal of Transplantation, Vol. 5, No. 11, 2005, pp. 2796-2798.
doi:10.1111/j.1600-6143.2005.01065.x
|
[8]
|
K. L. Nash, T. M. Yeung, P. J. Lehner, P. Gibbs and W. J. Griffiths, “Orthotopic Liver Transplantation for Subacute Hepatic Failure Following Partial Treatment of Isoni- az-id-Resistant Tuberculosis,” Transplant Infectious Disease, Vol. 10, No. 4, 2008, pp. 272-275.
doi:10.1111/j.1399-3062.2007.00277.x
|